# A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

> **NCT01044108** · PHASE1 · TERMINATED · sponsor: **Novo Nordisk A/S** · enrollment: 117 (actual)

## Conditions studied

- Metabolism and Nutrition Disorder
- Obesity

## Interventions

- **DRUG:** NNC 0070-0002-0453
- **DRUG:** '2-0453
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01044108
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01-05
- **Primary completion:** 2010-12-13
- **Final completion:** 2011-09-20
- **Target enrollment:** 117 (ACTUAL)
- **Why stopped:** See detailed description
- **Last updated:** 2017-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01044108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01044108, "A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01044108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*